CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1

This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example MedicationAdministration: MedicationAdministration-Example1

Generated Narrative: MedicationAdministration

Resource MedicationAdministration "MedicationAdministration-Example1"

Profile: CIBMTR Medication Administration (mcode)

Security Labels: http://terminology.cibmtr.org/codesystem/transplant-center

status: completed

medication: Medication/Medication-Etoposide-Example

subject: Patient/PatientExample6 ""

effective: 2020-07-22 16:58:05+0000

reasonCode: Cancer (CMS/HCC) (SNOMED CT#363346000 "Malignant neoplastic disease (disorder)"; International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)#C80.1 "Malignant (primary) neoplasm, unspecified")

request: MedicationRequest/MedicationRequest-Etoposide-Example

Dosages

-RouteMethodDose
*Intravenous route (SNOMED CT#47625008)Inject - dosing instruction imperative (qualifier value) (SNOMED CT#422145002)73 milligram (Details: UCUM code mg = 'mg')